Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Walk or cycle before cancer treatment: new study tests exercise boost

NCT ID NCT05358938

First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 31 times

Summary

This early-phase study tests whether 30 minutes of moderate exercise (like walking or cycling) right before standard immunotherapy can improve treatment for certain skin cancers (melanoma, squamous cell carcinoma, Merkel cell carcinoma). About 22 adults will exercise before each immunotherapy dose. The main goals are to see if people can stick with the exercise routine and whether it changes tumor markers or delays cancer return.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Moffitt Cancer Center

    Tampa, Florida, 33612, United States

Conditions

The condition(s) this trial relates to.

cutaneous neuroendocrine carcinoma melanoma Motor Activity skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.